发明名称 FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL
摘要 <p>Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e g insulin, dextrose, etc ) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.</p>
申请公布号 WO2011031351(A1) 申请公布日期 2011.03.17
申请号 WO2010US33794 申请日期 2010.05.05
申请人 OPTISCAN BIOMEDICAL CORPORATION;RULE, PETER 发明人 RULE, PETER
分类号 A61B5/00 主分类号 A61B5/00
代理机构 代理人
主权项
地址